Table 3.
Scale | Predicting variable(s)1 | OR2 | (95% CL) | P |
---|---|---|---|---|
Physical function | Age (per 10 year) | 1.53 | (1.36–1.74) | <.001 |
Sex (male vs. female) | 0.58 | (0.42–0.80) | 0.001 | |
Active treatment (yes vs. no) | 1.87 | (1.26–2.79) | 0.002 | |
Role function | Age (per 10 year) | 1.32 | (1.16–1.51) | <.001 |
Diagnosis: | 0.002 | |||
CLL | 1.01 | (0.66–1.55) | ||
CML | 1.24 | (0.62–2.47) | ||
AML | 1.14 | (0.56–2.31) | ||
Hodgkin lymphoma | 1.36 | (0.67–2.78) | ||
Non-Hodgkin lymphoma | 1.00 | – | ||
Multiple myeloma | 3.25 | (1.86–5.67) | ||
Other | 2.03 | (0.83–4.97) | ||
Emotional function | No significant predictors | |||
Social function | No significant predictors | |||
Cognitive function | Education: | |||
None | 1.79 | (0.94–3.42) | 0.005 | |
Semi-skilled worker (<1 yr) | 1.23 | (0.62–2.45) | ||
Skilled worker | 1.02 | (0.49–2.17) | ||
Short theoretical (1–3 years) | 1.00 | – | ||
Long theoretical (>3 years) | 0.71 | (0.40–1.28) | ||
Academic | 0.51 | (0.24–1.08) | ||
Age (per 10 year) | 1.18 | (1.05–1.32) | 0.006 | |
Quality of life | Active treatment (yes vs. no) | 1.96 | (1.31–2.92) | 0.001 |
Department: | ||||
Haematology | 1.00 | – | 0.007 | |
Medicine | 2.13 | (1.23–3.69) | ||
Other | 2.43 | (0.92–6.34) | ||
Fatigue | Active treatment (yes vs. no) | 1.85 | (1.25–2.74) | 0.002 |
Department: | ||||
Haematology | 1.00 | – | 0.006 | |
Medicine | 1.82 | (1.06–3.12) | ||
Other | 3.43 | (1.30–9.05) | ||
Pain | Age (per 10 year) | 1.28 | (1.13–1.45) | <.001 |
Nausea/vomiting | Contact type (hospitalised vs. out-patient) | 2.98 | (1.30–6.83) | 0.010 |
Dyspnoea | No significant predictors | |||
Appetite loss | Age (per 10 year) | 1.28 | (1.08–1.51) | 0.004 |
Active treatment (yes vs. no) | 2.03 | (1.25–3.29) | 0.004 | |
Contact type (hospitalised vs. out-patient) | 3.14 | (1.33–7.41) | 0.009 | |
Insomnia | Sex (male vs. female) | 0.46 | (0.33–0.66) | <.001 |
Diarrhoea | No significant predictors | |||
Constipation | Age (per 10 year) | 1.47 | (1.22–1.78) | <.001 |
Financial difficulties | Age (per 10 year) | 0.76 | (0.65–0.89) | <.001 |
CL, confidence limits; CLL, chronic lymphocytic leukaemia; CML, chronic myeloid leukaemia; AML, acute myeloid leukaemia.
Variables in the final model of the logistic regression.
An odds ratio above 1 reflects more functional limitations or more symptoms.